MARKET

FGEN

FGEN

Fibrogen Inc
NASDAQ
1.120
-0.040
-3.45%
After Hours: 1.120 0 0.00% 19:48 06/14 EDT
OPEN
1.180
PREV CLOSE
1.160
HIGH
1.180
LOW
1.100
VOLUME
991.67K
TURNOVER
0
52 WEEK HIGH
18.21
52 WEEK LOW
0.3333
MARKET CAP
111.41M
P/E (TTM)
-0.4575
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at FGEN last week (0603-0607)?
Weekly Report · 6d ago
FibroGen: Two New In-Licensed Oncology Drugs To Carry It Forward
FibroGen, Inc. Has shifted its focus into developing drugs to treat patients with cancer. Two drugs being developed as part of FibroGen's pipeline are FG-3165 andFG-3175. The drugs are in-licensed for the treatment of patients with solid tumors. The company has signed a collaboration agreement with Regeneron Pharmaceuticals to advance these drugs.
Seeking Alpha · 06/06 16:38
What's Going On With FibroGen Stock Tuesday?
FibroGen announced the FDA cleared its IND of FG-3165, allowing the company to initiate a Phase 1 clinical trial. FibroGen also announced a new clinical trial supply agreement with Regeneron Pharmaceuticals. The company's shares initially traded higher Tuesday morning.
Benzinga · 06/04 18:27
Stock Index Futures Slip on Growth Fears, U.S. JOLTs Report in Focus
NASDAQ · 06/04 11:25
Why HealthEquity Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Shares of Healthequity Inc rose sharply in today's pre-market trading. The company reported better-than-expected first-quarter financial results. MicroAlgo Inc rose 209.5% to $4.83. Core Scientific shares gained 51.8% in pre- market trading after the company announced plans to establish a quantum research center.
Benzinga · 06/04 09:50
Stock Index Futures Slip Ahead of U.S. JOLTs Report
June S&P 500 E-Mini futures are down -0.55% this morning ahead of the latest reading on U.S. Job openings. In yesterday's trading session, Wall Street's major indexes ended mixed. Paramount Global was the top percentage gainer on the S&p 500 and Boeing rose nearly +4%. Today, investors will focus on the U.s. JOLTs Job Openings data for April.
Barchart · 06/04 04:49
FibroGen stock rallies 30% after hours on FG-3165, FG-3175 updates
FibroGen stock rallies 30% after hours on FG-3165,FG-3175 updates. The company announced clinical updates on its drug candidates. The biotech company said the FDA has cleared its application to begin Phase 1 testing of the drug. FibroGen also said it has entered into a supply agreement with Regeneron.
Seeking Alpha · 06/03 21:38
FibroGen Stock Is Surging After The Bell: What's Going On?
FibroGen Inc (NASDAQ:FGEN) shares are moving higher in Monday's after-hours session. The company announced the FDA cleared its Investigational New Drug for FG-3165. FibroGen also announced a new clinical trial supply agreement with Regeneron.
Benzinga · 06/03 20:48
More
About FGEN
FibroGen, Inc. is a biopharmaceutical company. The Company is engaged in developing and commercializing a diversified pipeline of novel therapeutics that work at the frontiers of cancer biology and anemia. Its clinical, commercial, and research programs include Pamrevlumab, which is a first-in-class antibody being developed by FibroGen to inhibit the activity of connective tissue growth factor (CTGF). Pamrevlumab is in Phase III clinical development for the treatment of locally advanced unresectable pancreatic cancer (LAPC) and in Phase 2/3 for the treatment of metastatic pancreatic cancer and Roxadustat, an oral medication, is the first in a new class of medicines comprising HIF-PH inhibitors that promote erythropoiesis, or red blood cell production, through increased endogenous production of erythropoietin, improved iron absorption and mobilization, and downregulation of hepcidin. It also develops FG-3165: Anti-Gal9 Antibody and FG-3175: Anti-CCR8 Antibody.

Webull offers FibroGen Inc stock information, including NASDAQ: FGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FGEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FGEN stock methods without spending real money on the virtual paper trading platform.